ABL Bio Publishes Review Paper on Dual Antibodies in International Journal
ABL Bio announced on the 11th that it published a review paper on the next-generation immune-oncology dual antibody ‘4-1BB’ in the online edition of...
Search results for "Bio"
From Bathhouses to Biohacking: Why "Contrast Therapy" is 2026’s Hottest Wellness Trend
Move over, simple ice baths. The latest "it" keyword dominating the global wellness industry for 2026 is Contrast Therapy—the practice of alternating...
Launch of 'TrumpRX' Sells Drugs at Steep Discounts: Will Celltrion and Samsung Biologics Face Price Pressure?
The prescription drug sales platform 'TrumpRX', named after U. S. President Donald Trump, has officially launched.
LigaChemBio Receives Milestone from Czech Sotio Biotech
LigaChem Biosciences announced on the 9th that it will receive milestone payments based on successful product...
Samsung Bioepis Aflibercept Biosimilar Available for Sale in Europe
Samsung Bioepis announced on the 30th that it has signed a patent agreement and licensing contract with the original...
Samsung Bioepis Achieves Record Sales of 1.672 Trillion Won Last Year
Samsung Bioepis achieved its highest performance last year in terms of sales. Excluding short-term milestone revenues,...
K-Toxins Heading to China... Will Hugel Be Followed After 5 Years in the Top 3?
Domestic botulinum toxin companies are racing towards the Chinese market. With Hugel, which entered China first,...
SK Bioscience Accelerates Development of Next-Generation Zaire Ebola Vaccine
SK Bioscience is accelerating the development of the next-generation Ebola vaccine with funding support from the...
Capture the 0.02% Micro Signal in Blood...Bio Venture GraBis Challenging Early Cancer Diagnosis
“If you miss one tiny signal, you could lose a life (Missing one tiny signal Cost a Life).
SK Biopharm Receives FDA Approval for Clinical Trial Plan of Alpha-emitting Radiopharmaceuticals
SK Biopharm announced on the 12th that it has received approval from the U.S. Food and Drug Administration for the...